Literature DB >> 10891441

The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3.

L Velazquez1, G D Gish, P van Der Geer, L Taylor, J Shulman, T Pawson.   

Abstract

The Shc adaptor protein possesses 2 distinct phosphotyrosine (pTyr) recognition modules-the pTyr binding (PTB) domain and the Src homology 2 (SH2) domain-and multiple potential sites for tyrosine (Tyr) phosphorylation (Tyr residues 239, 240, and 317). On stimulation of hematopoietic cells with interleukin 3 (IL-3), Shc becomes phosphorylated and may therefore contribute to IL-3 signaling. We investigated the interactions mediated by the Shc modular domains and pTyr sites in IL-3-dependent IC2 premast cells. The Shc PTB domain, rather than the SH2 domain, associated both in vitro and in vivo with the Tyr-phosphorylated beta subunit of the IL-3 receptor and with the SH2-containing 5' inositol phosphatase (SHIP), and it recognized specific NXXpY phosphopeptides from these binding partners. In IL-3-stimulated mast cells, Shc phosphorylation occurred primarily on Tyr239 and 317 and was dependent on a functional PTB domain. Phosphorylated Tyr317, and to a lesser extent, Tyr239, bound the Grb2 adaptor and SHIP. Furthermore, a pTyr317 Shc phosphopeptide selectively recognized Grb2, Sos1, SHIP, and the p85 subunit of phosphatidylinositol 3' kinase from mast cells, as characterized by mass spectrometry. These results indicate that Shc undergoes an interdependent series of pTyr-mediated interactions in IL-3-stimulated mast cells, resulting in the recruitment of proteins that regulate the Ras pathway and phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891441

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1.

Authors:  Matthew J Smith; W Rod Hardy; Guang-Yao Li; Marilyn Goudreault; Steven Hersch; Pavel Metalnikov; Andrei Starostine; Tony Pawson; Mitsuhiko Ikura
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

2.  Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.

Authors:  Silvia Ginés; Paola Paoletti; Jordi Alberch
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

3.  Directed network wiring identifies a key protein interaction in embryonic stem cell differentiation.

Authors:  Norihisa Yasui; Greg M Findlay; Gerald D Gish; Marilyn S Hsiung; Jin Huang; Monika Tucholska; Lorne Taylor; Louis Smith; W Clifford Boldridge; Akiko Koide; Tony Pawson; Shohei Koide
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

4.  The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.

Authors:  Hayley S Ramshaw; Mark A Guthridge; Frank C Stomski; Emma F Barry; Lisa Ooms; Christina A Mitchell; C Glenn Begley; Angel F Lopez
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

5.  The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2.

Authors:  Stefan Hanke; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2008-11-11       Impact factor: 5.911

6.  Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice.

Authors:  Laura Velazquez; Alec M Cheng; Heather E Fleming; Caren Furlonger; Shirly Vesely; Alan Bernstein; Christopher J Paige; Tony Pawson
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

7.  Prediction of phosphotyrosine signaling networks using a scoring matrix-assisted ligand identification approach.

Authors:  Lei Li; Chenggang Wu; Haiming Huang; Kaizhong Zhang; Jacob Gan; Shawn S-C Li
Journal:  Nucleic Acids Res       Date:  2008-04-19       Impact factor: 16.971

8.  Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.

Authors:  Mélissa Landry; Véronique Pomerleau; Caroline Saucier
Journal:  Biochem J       Date:  2016-04-05       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.